Ms Brisa Simoes Fernandes

STAFF PROFILE

Position

Visitor

Faculty

Faculty of Health

Department

School of Medicine

Campus

Barwon Health

Biography

I am a psychiatrist and scientist. My main research field focuses on the discovery and application of biomarkers in severe mental illnesses, namely bipolar disorder, major depressive disorder, and schizophrenia. I started in this field in 2008 during my psychiatric training and in 2009 published what is perhaps the first proposal of employment of blood biomarkers as an adjunctive tool for the differential diagnosis of bipolar and unipolar depression. My masters degree investigated and proposed the protein brain-derived neurotrophic factor (BDNF) as a biomarker of disease activity in bipolar disorder, showing it decreased in mania and depression, reflecting severity of the mood states, and normal in euthymia. It was awarded the Samuel Gershon Award for Junior Investigator by The International Society for Bipolar Disorders (ISBD) in 2010, and the article published is on top 1% most cited papers in Psychiatry and Psychology according to Web of Science Indicators. Subsequently, in order to obtain deeper knowledge in neuroscience, I enroled for a doctorate in Biochemistry at Federal University of Rio Grande do Sul (UFRGS), one of the leading universities in Brazil. My Ph.D. thesis analysed, among other points, the role of peripheral BDNF as a biomarker across the schizoaffective spectrum and establish that BDNF is a potential biomarker of disease activity for the acute phases of bipolar disorder and major depressive disorder. My thesis originated two papers that were published at Molecular Psychiatry, the leading journal in my field, in 2013 and 2014. Presently, I am a post-doctoral research fellow in Australia at Deakin University, School of Medicine, under the supervision of Prof. Michael Berk, a well-known expert in bipolar disorder. I am an active researcher, with more than 25 articles in peer-reviewed journals, an H-index of 15 and more than 1,000 citations (Google Scholar, July 2015). Currently, I hold a research grant from CNPq (Brazilian National Council for Scientific and Technological Development), a very competitive grant with high rejections rate. I graduated in Medicine in 2002 and specialised in Internal Medicine and Psychiatry in 2005 and 2009, respectively. During my graduation years, I acquired extensive experience in Epidemiology, and my residency training in Internal Medicine provided me a deep understanding of clinical tests and its applications. Contact: brisasf@gmail.com or brisasf@pq.cnpq.br.

Read more on Brisa's profile

Biography summary

I am a psychiatrist and scientist. My research field focuses on the discovery and application of biomarkers in severe mental illnesses, namely bipolar disorder, major depressive disorder, and schizophrenia. I started in this field in 2008 during my psychiatric training and in 2009 published what is perhaps the first proposal of employment of blood biomarkers as an adjunctive tool for the differential diagnosis of bipolar and unipolar depression. My masters degree investigated the protein BDNF as a biomarker of disease activity in bipolar disorder, and it is on the top 1% most cited papers according to Web of Science. Subsequently, I enroled for a doctorate in Biochemistry at UFRGS, Brazil. My Ph.D. thesis established that BDNF is a biomarker of disease activity for the acute phases of bipolar disorder and major depressive disorder. Presently, I am a post-doctoral research fellow in Australia at Deakin University. I am an active researcher, with an H-index of 15 and more than 1,000 citations.

Research interests

  • Biomarkers in Psychiatry
  • Bipolar Disorder
  • Translational Psychiatry
  • Neuroscience & Biological Psychiatry

Teaching interests

  • Psychiatry

Knowledge areas

  • Biomarkers in Psychiatry
  • Bipolar Disorder & Major Depressive Disorder
  • Schizophrenia & Psychosis
  • Neuroscience & Biological Psychiatry
  • Translational Psychiatry
  • Systematic Reviews & Meta-Analysis

Media appearances

A Healthy Outlook. The Weekly Review, Australia, p. 8 - 8, 18 dez. 2014. http://issuu.com/theweeklyreview.com.au/docs/gee-greatergeelong-20141218-iss

Awards

  • Top 1% of the Academic field of Psychiatry and Psychology paper based on a highly cited threshold for the field and publication year, for the paper "Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis", Journal of Psychiatric Research, according to Web of Science and Essential Science Indicators, 2015.
  • Number 1 Most Cited Journal of Psychiatric Research Articles - "Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis", Journal of Psychiatric Research, 2013 to present.
  • Most Cited Journal of Affective Disorders Articles - "Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder", Journal of Affective Disorders, 2012 to present.
  • Top Read Articles of 2012 for the paper “Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomised placebo-controlled trial”, the editors of MDLinx.
  • Samuel Gershon Award for Junior Investigators, SGAJI – for the research “Serum brain-derived neurotrophic factor in bipolar disorder: a meta-analysis and meta-regression study”, International Society for Bipolar Disorders, 2010.
  • Valentim Gentil Honors Award – for the poster “Serum brain-derived neurotrophic factor in bipolar disorder: a meta-analysis and metarregression study”, Simpósio Internacional de Transtornos do Humor e seu Espectro, Brazilian Society for Bipolar Disorders, Brazil, 2010.
  • Professor Antônio Zuardi Award – for the poster “Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis”, XII Brazilian Meeting of Psychiatry, Brazil, 2009.
  • FeSBE Honors Award – for the poster "Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients”, 2009.
  • UFCSPA Honors – for the oral presentation “Increased Neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes”, Federal University of Health Sciences of Porto Alegre, Brazil, 2009.
  • Society of Cardiology of Rio Grande do Sul Meeting Award – for the oral presentation “Off-pump coronary artery bypass surgery does not reduce lymphocyte activation”, Society of Cardiology of Rio Grande do Sul, Brazil, 2002.
  • Eduardo Moacyr Krieger Award – for the oral presentation "Incidence of hypertension in Porto Alegre, Brazil: a population-based study", Brazilian Hypertension Society, Brazil, 2002.
  • XIV Salão de Iniciação Científica Honors – for the oral presentation “Incidence of hypertension in Porto Alegre, Brazil: a population-based study”, Universidade Federal do Rio Grande do Sul, Brazil, 2002.

Projects

Geelong Bipolar Disorder Health and Lifestyle Study: 

Bipolar disorder (BD) is a multidimensional condition, involving a complex and dynamic interaction between biological, lifestyle and psychosocial factors. It imposes huge personal and public costs, with between 30 and 60% of patients experiencing significant disability in areas such as social, occupational, and family functioning. BD is associated with significant suffering, mortality and medical morbidity and remains among the ten leading causes of disability worldwide. Despite this, BD has received relatively little research attention. As a result, its physiological factors are poorly understood or described. Moreover, there are few extant data concerning the impact of BD on medical illness and related conditions. Furthermore, research shows that the problems experienced by people with BD are closely related to the supports provided by environmental agents such as family, community, health services, public policy and service systems. Extending knowledge of the disorder is therefore necessary to inform service delivery to improve outcomes associated with the disease. While there is an increasing body of evidence on the importance of lifestyle factors such as diet, exercise and smoking in depression, a comparable evidence base remains to be gathered for BD. This study will gather data on all of these domains. This study will compare people diagnosed with BD to those in good psychological health. It will provide a valuable insight into the lifestyle factors (diet, smoking exercise) associated with the disorder and the medical consequences at a population level. It will be capable of discerning a range of critical associations between psychiatric and medical disorders and other lifestyle and social outcomes. These data are required to form a coherent public health message for BD, and develop interventions that target lifestyle factors.

Publications

Filter by

2020

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment

J Steiner, T Frodl, K Schiltz, H Dobrowolny, R Jacobs, B Fernandes, P Guest, G Meyer-Lotz, K Borucki, S Bahn, B Bogerts, P Falkai, H Bernstein

(2020), Vol. 46, pp. 363-373, Schizophrenia bulletin, Oxford, England, C1

journal article

Precision psychiatry with immunological and cognitive biomarkers: a multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning

Brisa Fernandes, Chandan Karmakar, Ryad Tamouza, Truyen Tran, John Yearwood, Nora Hamdani, Hakim Laouamri, Jean-Romain Richard, Robert Yolken, Michael Berk, Svetha Venkatesh, Marion Leboyer

(2020), Vol. 10, pp. 1-13, Translational Psychiatry, Berlin, Germany, C1

journal article
2019

Progressing Towards Precision Psychiatry Current Challenges in Applying Biomarkers in Psychiatry

Victor Kallen, Brisa Fernandes

(2019), pp. 520-528, Handbook of biomarkers and precision medicine, Boca Raton, Flo., B1

book chapter

Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? - A monozygotic twin study

N Ottesen, I Meluken, R Frikke-Schmidt, P Plomgaard, T Scheike, B Fernandes, M Berk, H Poulsen, L Kessing, K Miskowiak, M Vinberg

(2019), pp. 1-10, Psychological Medicine, Cambridge, Eng., C1

journal article
2018

Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials

D Brownstein, E Salagre, C Khler, B Stubbs, J Vian, C Pereira, V Chavarria, C Karmakar, A Turner, J Quevedo, A Carvalho, M Berk, B Fernandes

(2018), Vol. 52, pp. 24-38, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal article

Aspirin and incident depressive symptoms: a longitudinal cohort study over 8 years

N Veronese, A Koyanagi, B Stubbs, M Solmi, M Fornaro, B Fernandes, C Muller, T Thompson, A Carvalho, S Maggi

(2018), Vol. 33, pp. e193-e198, International journal of geriatric psychiatry, Chichester, Eng., C1

journal article

Early intervention in Bipolar Disorder

Eduard Vieta, Estela Salagre, Iria Grande, Andr Carvalho, Brisa Fernandes, Michael Berk, Boris Birmaher, Mauricio Tohen, Trisha Suppes

(2018), Vol. 175, pp. 411-426, American journal of psychiatry, Arlington, Va., C1

journal article

Glucose homeostasis in major depression and schizophrenia: a comparison among drug-nave first-episode patients

Johann Steiner, Brisa Fernandes, Paul Guest, Henrik Dobrowolny, Gabriela Meyer-Lotz, Sabine Westphal, Katrin Borucki, Kolja Schiltz, Zoltn Sarnyai, Hans-Gert Bernstein

(2018), European Archives of Psychiatry and Clinical Neuroscience, Heidelberg, Germany, C1

journal article

Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis

Che-Sheng Chu, Ping-Tao Tseng, Brendon Stubbs, Tien-Yu Chen, Chia-Hung Tang, Dian-Jeng Li, Wei-Cheng Yang, Yen-Wen Chen, Ching-Kuan Wu, Nicola Veronese, Andre Carvalho, Brisa Fernandes, Nathan Herrmann, Pao-Yen Lin

(2018), Vol. 8, pp. 1-12, Scientific reports, London, Eng., C1

journal article

Imaging genetics paradigms in depression research: systematic review and meta-analysis

Lcia Pereira, Cristiano Khler, Brendon Stubbs, Kamilla Miskowiak, Gerwyn Morris, Brbara de Freitas, Trevor Thompson, Brisa Fernandes, Andr Brunoni, Michael Maes, Diego Pizzagalli, Andr Carvalho

(2018), Vol. 86, pp. 102-113, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

journal article

Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and Mendelian randomization studies

Cristiano Khler, Evangelos Evangelou, Brendon Stubbs, Marco Solmi, Nicola Veronese, Lazaros Belbasis, Beatrice Bortolato, Matias Melo, Camila Coelho, Brisa Fernandes, Mark Olfson, John Ioannidis, Andr Carvalho

(2018), Vol. 103, pp. 189-207, Journal of psychiatric research, Amsterdam, The Netherlands, C1

journal article

Leaky brain in neurological and psychiatric disorders: drivers and consequences

Gerwyn Morris, Brisa Fernandes, Basant Puri, Adam Walker, Andre Carvalho, Michael Berk

(2018), Vol. 52, pp. 924-948, Australian and New Zealand journal of psychiatry, London, Eng., C1

journal article
2017

Depression in cancer: the many biobehavioral pathways driving tumor progression

B Bortolato, T Hyphantis, S Valpione, G Perini, M Maes, G Morris, M Kubera, C Khler, B Fernandes, B Stubbs, N Pavlidis, A Carvalho

(2017), Vol. 52, pp. 58-70, Cancer treatment reviews, Amsterdam, The Netherlands, C1

journal article

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

C Khler, T Freitas, M Maes, N de Andrade, C Liu, B Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann, C Raison, B Miller, K Lanctt, A Carvalho

(2017), Vol. 135, pp. 373-387, Acta psychiatrica scandinavica, Chichester, Eng., C1

journal article

The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes

V Chavarria, J Vian, C Pereira, J Data-Franco, B Fernandes, M Berk, S Dodd

(2017), Vol. 39, pp. 477-486, Clinical therapeutics, New York, N.Y., C1

journal article

Oxidative stress and frailty: a systematic review and synthesis of the best evidence

P Soysal, A Isik, A Carvalho, B Fernandes, M Solmi, P Schofield, N Veronese, B Stubbs

(2017), Vol. 99, pp. 66-72, Maturitas, Amsterdam, The Netherlands, C1

journal article

Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis

E Salagre, A Vizuete, M Leite, D Brownstein, A McGuinness, F Jacka, S Dodd, B Stubbs, C Khler, E Vieta, A Carvalho, M Berk, B Fernandes

(2017), Vol. 43, pp. 81-91, European psychiatry, Amsterdam, The Netherlands, C1

journal article

Relationship between depression and frailty in older adults: a systematic review and meta-analysis

P Soysal, N Veronese, T Thompson, K Kahl, B Fernandes, A Prina, M Solmi, P Schofield, A Koyanagi, P-T Tseng, P-Y Lin, C-S Chu, T Cosco, M Cesari, A Carvalho, B Stubbs

(2017), Vol. 36, pp. 78-87, Ageing research reviews, Amsterdam, The Netherlands, C1

journal article

the effect of n-acetylcysteine (nac) on human cognition - a systematic review

D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott

(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1

journal article

Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis

C Khler, T Freitas, B Stubbs, M Maes, M Solmi, N Veronese, N de Andrade, G Morris, B Fernandes, A Brunoni, N Herrmann, C Raison, B Miller, K Lanctt, A Carvalho

(2017), Vol. 55, pp. 4195-4206, Molecular neurobiology, New York, N.Y., C1

journal article

Treatment of neurocognitive symptoms in unipolar depression: a systematic review and future perspectives

E Salagre, B Sol, Y Tomioka, B Fernandes, D Hidalgo-Mazzei, M Garriga, E Jimenez, J Sanchez-Moreno, E Vieta, I Grande

(2017), Vol. 221, pp. 205-221, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

journal article

The renin-angiotensin system: a possible new target for depression

J Vian, C Pereira, V Chavarria, C Khler, B Stubbs, J Quevedo, S-W Kim, A Carvalho, M Berk, B Fernandes

(2017), Vol. 15, pp. 144-156, BMC Medicine, London, Eng., C1

journal article

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd

(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1

journal article
2016

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonalves, M Berk

(2016), Vol. 21, pp. 554-564, Molecular psychiatry, London, Eng., C1

journal article

Effects of depression and serotonergic antidepressants on bone: Mechanisms and implications for the treatment of depression

B Fernandes, J Hodge, J Pasco, M Berk, L Williams

(2016), Vol. 33, pp. 21-25, Drugs & aging, Berlin, Germany, C1

journal article

Cognitive remission: a novel objective for the treatment of major depression?

B Bortolato, K Miskowiak, C Khler, M Maes, B Fernandes, M Berk, A Carvalho

(2016), Vol. 14, pp. 1-18, BMC medicine, London, Eng., C1

journal article

Bias in peripheral depression biomarkers

A Carvalho, C Khler, A Brunoni, K Miskowiak, N Herrmann, K Lanctt, T Hyphantis, J Quevedo, B Fernandes, M Berk

(2016), Vol. 85, pp. 81-90, Psychotherapy and psychosomatics, Basel, Switzerland, C1

journal article

T helper 17 cells may drive neuroprogression in major depressive disorder: proposal of an integrative model

A Slyepchenko, M Maes, C Khler, G Anderson, J Quevedo, G Alves, M Berk, B Fernandes, A Carvalho

(2016), Vol. 64, pp. 83-100, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

journal article

Leptin in bipolar disorder: a systematic review and meta-analysis

B Fernandes, S Dash, F Jacka, S Dodd, A Carvalho, C Khler, J Steiner, M da Graa Cantarelli, P Nardin, C Gonalves, M Berk

(2016), Vol. 35, pp. 1-7, European psychiatry, Amsterdam, The Netherlands, C1

journal article

N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis

B Fernandes, O Dean, S Dodd, G Malhi, M Berk

(2016), Vol. 77, pp. 457-466, Journal of clinical psychiatry, Memphis, Tenn., C1

journal article

Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials

E Salagre, B Fernandes, S Dodd, D Brownstein, M Berk

(2016), Vol. 200, pp. 235-242, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal article

Affective temperaments and emotional traits are associated with a positive screening for premenstrual dysphoric disorder

R Cmara, C Khler, M Maes, P Nunes-Neto, A Brunoni, J Quevedo, B Fernandes, G Perugi, T Hyphantis, A Carvalho

(2016), Vol. 71, pp. 33-38, Comprehensive psychiatry, Amsterdam, The Netherlands, C1

journal article

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

B Fernandes, J Steiner, M Molendijk, S Dodd, P Nardin, C-A Gonalves, F Jacka, C Khler, C Karmakar, A Carvalho, M Berk

(2016), Vol. 3, pp. 1147-1156, Lancet psychiatry, Amsterdam, The Netherlands, C1

journal article
2015

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, M Berk, M Molendijk, A Gonzalez-Pinto, C Turck, P Nardin, C Gonalves

(2015), Vol. 20, pp. 1108-1119, Molecular Psychiatry, London, Eng., C1

journal article

Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis

A Carvalho, C Khler, R McIntyre, C Knchel, A Brunoni, M Thase, J Quevedo, B Fernandes, M Berk

(2015), Vol. 62, pp. 18-26, Psychoneuroendocrinology, Amsterdam, The Netherlands, C1

journal article

Future directions for pharmacotherapies for treatment-resistant bipolar disorder

S Dodd, B Simoes Fernandes, O Dean

(2015), Vol. 13, pp. 656-662, Current neuropharmacology, Bussum, The Netherlands, C1

journal article

Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders

M da Graa Cantarelli, P Nardin, A Buffon, M Eidt, L Godoy, B Fernandes, C-A Gonalves

(2015), Vol. 172, pp. 403-409, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

journal article

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies

B Fernandes, M Molendijk, C Kohler,, J Soares, C Leite, R Machado-Vieria, T Ribeiro, J Silva, P Sales, J Quevedo, V Oertel-Knochel, E Vieta, A Gonzalez-Pinto, M Berk, A Carvalho

(2015), Vol. 13, pp. 1-22, BMC Medicine, London, Eng., C1

journal article
2013

Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

B Frey, A Andreazza, J Houenou, S Jamain, B Goldstein, M Frye, M Leboyer, M Berk, G Malhi, C Lopez-Jaramillo, V Taylor, S Dodd, S Frangou, G Hall, B Fernandes, M Kauer-Sant'Anna, L Yatham, F Kapczinski, L Young

(2013), Vol. 47, pp. 321-332, Australian and New Zealand Journal of Psychiatry, C1-1

journal article

The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies

Kleber Santos, Andre Palmini, Ana Radziuk, Rosana Rotert, Fernanda Bastos, Linda Booij, Brisa Fernandes

(2013), Vol. 55, pp. 654-660, Developmental medicine and child neurology, Chichester, Eng., C1

journal article
2012

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi

(2012), Vol. 10, BMC Medicine, C1

journal article

Reduced serum non-enzymatic antioxidant defense and increased lipid peroxidation in schizophrenic patients on a hypocaloric diet

K Zortea, B Simoes Fernandes, L Guimares, L Francesconi, C Lersch, C Gama, R Schroeder, A Zanotto-Filho, J Moreira, M Lobato, P Belmonte-de-Abreu

(2012), Vol. 512, pp. 43-47, Neuroscience letters, Amsterdam, The Netherlands, C1

journal article
2011

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi

(2011), Vol. 135, pp. 389-394, Journal of Affective Disorders, C1

journal article
2009

Improvement of negative and positive symptoms in treatment-refractory schizophrenia : a double-blind, randomized, placebo-controlled trial with memantine as add-On therapy to clozapine

D De Lucena, B Fernandes, M Berk, S Dodd, D Medeiros, M Pedrini, M Kunz, F Gomes, L Giglio, M Lobato, P Belmonte-de-Abreu, C Gama

(2009), Vol. 70, pp. 1416-1423, Journal of clinical psychiatry, Memphis, Tenn., C1-1

journal article

Funded Projects at Deakin

Australian Competitive Grants

The Candesartan Adjunctive bipolar DEpression Trial - CADET

Prof Michael Berk, Prof Gin Malhi, A/Prof Chee Ng, Prof Malcolm Hopwood, Ms Brisa Simoes Fernandes, Dr Stella Gwini, Dr John Amerena, Dr Mary Lou Chatterton, Prof Trisha Suppes, A/Prof Lana Williams

MRFF Clinical Trials Activity: Rare Cancers, Rare Diseases and Unmet Need Grant

  • 2020: $116,840
  • 2019: $2,103,202

The Candesartan Adjunctive Major Depression Trial - CADET: A double-blind, randomised, placebo-controlled trial

Prof Michael Berk, Ms Brisa Simoes Fernandes, Dr Mary Lou Chatterton, A/Prof Lana Williams

NHMRC - Clinical Trials and Cohort Studies Grant

  • 2020: $93,796

Supervisions

No completed student supervisions to report